Facial Aesthetics Market By Product (Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, Others), By Application (Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, Others), By End User (Specialty and Dermatology Clinics, Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global facial aesthetics market was valued at $6,234.5 million in 2021, and is projected to reach $25,764.5 million by 2031, registering a CAGR of 15.5% from 2022 to 2031. Facial aesthetics is a non-surgical procedure that revitalizes the skin. It is a facial rejuvenation treatment that reduces signs of ageing on the face. Facial aesthetic procedures provide more youthful and radiant appearance. The treatment offers facial contouring, defines certain facial features and it can soften wrinkles. Non-surgical aesthetic treatment helps in lifting up the confidence of people by improving the smile or skin in and masking the effect of age in less complicated way. Facial aesthetic procedure helps reduce and eliminate facial lines and wrinkles, it can treat scar and blemishes, it removes thicker and uneven skin layer and has many other benefits. In addition, non-surgical aesthetic procedures ensure quicker recovery and lesser pain than traditional surgical cosmetic procedures.
The facial aesthetics market is driven by rise in shift of customers toward minimally invasive and non-invasive procedures, increase in number of non-surgical aesthetic procedures such as facial contouring, Botox, injections, facial fillers and other, rise in awareness regarding skin health, and surge in expenditure on human healthcare services boosts growth of the market. According to a report by the American society of plastic surgeons (ASPS), in 2020, it was reported that around 16 million cosmetic procedures are conducted, globally. As per the same source, it was also reported that consumers spent approximately $20 billion on facial aesthetics procedures globally for total consumers. Moreover, according to a report shared by American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) in February 2022, total number of surgical and non-surgical procedures was 1.4 million in 2021, and have increased by 40% than 2020.
In addition, rise in number of botulinum toxin procedure which is also known as Botox injection anticipated to fuel the market growth. For instance, according to a report by Statista, published in 2021, botulinum toxin is the highest non-surgical procedure performed worldwide. Approximately 2.6 million botulinum toxin procedures were performed in 2020 across the globe. Moreover, rise in self-awareness among people regarding aesthetic appearance anticipated to propel the growth of facial aesthetics market. However, side effects associated with facial aesthetic procedures and high cost of procedures are anticipated to hinder the market growth during the forecast period. Side effects such as pain, swelling or bruising at injection site, skin rashes, skin infection hinder growth of the market. Development of products with advanced technologies for facial aesthetic procedures boost demand for facial aesthetics and provide growth opportunities for the facial aesthetics market. For instance, Galderma is a dermatology and pharmaceutical company, which received approval for two products. In May 2020, it received Food & Drug Administration (FDA) approval for restylane kysse, a new hyaluronic acid (ha) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth.
The global facial aesthetics market is segmented on the basis of product, application, end user and region. The product segment is further classified into dermal fillers, botulinum toxin, microdermabrasion, chemical peels and others. On the basis of application, it is segmented into facial line correction treatment, scar treatment, lip enhancement, restoration of volume/ fullness and others.
On the basis end user, the market is categorized into specialty & dermatology clinics, hospitals and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global facial aesthetics market include AbbVie, Anika Therapeutics, Inc., Bausch Health Companies Inc., Candela Syneron, Cutera, Inc., Cynosure, Elan aesthetics, Evolus Inc., Fotona D.O.O, Galderma Laboratories, Ipsen, Johnson and Johnson, Merz Pharma, Revance Therapeutics, Sinclair Pharma, Teoxane, and Vital Esthetique.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the facial aesthetics market analysis from 2021 to 2031 to identify the prevailing facial aesthetics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the facial aesthetics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global facial aesthetics market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Dermal fillers
Botulinum toxin
Microdermabrasion
Chemical peels
Others
By Application
Facial line correction treatment
Scar treatment
Lip enhancement
Restoration of volume or Fullness
Others
By End User
Specialty and Dermatology Clinics
Hospitals
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest Of Europe
Asia-Pacific
China
Japan
India
Australia
Rest Of Asia Pacific
LAMEA
Brazil
Saudi Arabia
Colombia
Rest of LAMEA
Key Market Players
Abbvie Inc
merz pharma
galderma laboratories, l.p.
Candela Syneron
Vital Esthetique
Teoxane
Johnson and Johnson
Cynosure
Bausch Health Companies Inc.
Sinclair Pharmaceuticals Limited
ipsen
Fotona D.O.O
Elan aesthetics
Anika Therapeutics, Inc.
Cutera, Inc.
Evolus Inc.
Revance Therapeutics
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: FACIAL AESTHETICS MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Dermal fillers
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Botulinum toxin
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Microdermabrasion
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Chemical peels
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Others
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
- CHAPTER 5: FACIAL AESTHETICS MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Facial line correction treatment
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Scar treatment
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Lip enhancement
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Restoration of volume or Fullness
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- 5.6 Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
- CHAPTER 6: FACIAL AESTHETICS MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Specialty and Dermatology Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Hospitals
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: FACIAL AESTHETICS MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product
- 7.2.5.1.2 Market size and forecast, by Application
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product
- 7.2.5.2.2 Market size and forecast, by Application
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product
- 7.2.5.3.2 Market size and forecast, by Application
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product
- 7.3.5.1.2 Market size and forecast, by Application
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product
- 7.3.5.2.2 Market size and forecast, by Application
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Product
- 7.3.5.3.2 Market size and forecast, by Application
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product
- 7.3.5.4.2 Market size and forecast, by Application
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product
- 7.3.5.5.2 Market size and forecast, by Application
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest Of Europe
- 7.3.5.6.1 Market size and forecast, by Product
- 7.3.5.6.2 Market size and forecast, by Application
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Product
- 7.4.5.1.2 Market size and forecast, by Application
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Product
- 7.4.5.2.2 Market size and forecast, by Application
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Product
- 7.4.5.3.2 Market size and forecast, by Application
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Product
- 7.4.5.4.2 Market size and forecast, by Application
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 Rest Of Asia Pacific
- 7.4.5.5.1 Market size and forecast, by Product
- 7.4.5.5.2 Market size and forecast, by Application
- 7.4.5.5.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product
- 7.5.5.1.2 Market size and forecast, by Application
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product
- 7.5.5.2.2 Market size and forecast, by Application
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 Colombia
- 7.5.5.3.1 Market size and forecast, by Product
- 7.5.5.3.2 Market size and forecast, by Application
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product
- 7.5.5.4.2 Market size and forecast, by Application
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Abbvie Inc
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 merz pharma
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 galderma laboratories, l.p.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Candela Syneron
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Vital Esthetique
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Teoxane
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Johnson and Johnson
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Cynosure
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Bausch Health Companies Inc.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Sinclair Pharmaceuticals Limited
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 ipsen
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Fotona D.O.O
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 Elan aesthetics
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 Anika Therapeutics, Inc.
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 Cutera, Inc.
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 Evolus Inc.
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 Revance Therapeutics
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 2. FACIAL AESTHETICS MARKET REVENUE, FOR DERMAL FILLERS, BY REGION , 2021-2031,($MILLION)
- TABLE 3. FACIAL AESTHETICS MARKET FOR DERMAL FILLERS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 4. FACIAL AESTHETICS MARKET REVENUE, FOR BOTULINUM TOXIN, BY REGION , 2021-2031,($MILLION)
- TABLE 5. FACIAL AESTHETICS MARKET FOR BOTULINUM TOXIN BY COUNTRY, 2021-2031,($MILLION)
- TABLE 6. FACIAL AESTHETICS MARKET REVENUE, FOR MICRODERMABRASION, BY REGION , 2021-2031,($MILLION)
- TABLE 7. FACIAL AESTHETICS MARKET FOR MICRODERMABRASION BY COUNTRY, 2021-2031,($MILLION)
- TABLE 8. FACIAL AESTHETICS MARKET REVENUE, FOR CHEMICAL PEELS, BY REGION , 2021-2031,($MILLION)
- TABLE 9. FACIAL AESTHETICS MARKET FOR CHEMICAL PEELS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 10. FACIAL AESTHETICS MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
- TABLE 11. FACIAL AESTHETICS MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 12. GLOBAL FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 13. FACIAL AESTHETICS MARKET REVENUE, FOR FACIAL LINE CORRECTION TREATMENT, BY REGION , 2021-2031,($MILLION)
- TABLE 14. FACIAL AESTHETICS MARKET FOR FACIAL LINE CORRECTION TREATMENT BY COUNTRY, 2021-2031,($MILLION)
- TABLE 15. FACIAL AESTHETICS MARKET REVENUE, FOR SCAR TREATMENT, BY REGION , 2021-2031,($MILLION)
- TABLE 16. FACIAL AESTHETICS MARKET FOR SCAR TREATMENT BY COUNTRY, 2021-2031,($MILLION)
- TABLE 17. FACIAL AESTHETICS MARKET REVENUE, FOR LIP ENHANCEMENT, BY REGION , 2021-2031,($MILLION)
- TABLE 18. FACIAL AESTHETICS MARKET FOR LIP ENHANCEMENT BY COUNTRY, 2021-2031,($MILLION)
- TABLE 19. FACIAL AESTHETICS MARKET REVENUE, FOR RESTORATION OF VOLUME OR FULLNESS, BY REGION , 2021-2031,($MILLION)
- TABLE 20. FACIAL AESTHETICS MARKET FOR RESTORATION OF VOLUME OR FULLNESS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 21. FACIAL AESTHETICS MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
- TABLE 22. FACIAL AESTHETICS MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 23. GLOBAL FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 24. FACIAL AESTHETICS MARKET REVENUE, FOR SPECIALTY AND DERMATOLOGY CLINICS, BY REGION , 2021-2031,($MILLION)
- TABLE 25. FACIAL AESTHETICS MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 26. FACIAL AESTHETICS MARKET REVENUE, FOR HOSPITALS, BY REGION , 2021-2031,($MILLION)
- TABLE 27. FACIAL AESTHETICS MARKET FOR HOSPITALS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 28. FACIAL AESTHETICS MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
- TABLE 29. FACIAL AESTHETICS MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 30. FACIAL AESTHETICS MARKET, BY REGION, 2021-2031,($MILLION)
- TABLE 31. NORTH AMERICA FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 32. NORTH AMERICA FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 33. NORTH AMERICA FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 34. NORTH AMERICA FACIAL AESTHETICS MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 35. U.S. FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 36. U.S. FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 37. U.S. FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 38. CANADA FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 39. CANADA FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 40. CANADA FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 41. MEXICO FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 42. MEXICO FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 43. MEXICO FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 44. EUROPE FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 45. EUROPE FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 46. EUROPE FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 47. EUROPE FACIAL AESTHETICS MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 48. GERMANY FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 49. GERMANY FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 50. GERMANY FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 51. FRANCE FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 52. FRANCE FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 53. FRANCE FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 54. U.K. FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 55. U.K. FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 56. U.K. FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 57. ITALY FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 58. ITALY FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 59. ITALY FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 60. SPAIN FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 61. SPAIN FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 62. SPAIN FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 63. REST OF EUROPE FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 64. REST OF EUROPE FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 65. REST OF EUROPE FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 66. ASIA-PACIFIC FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 67. ASIA-PACIFIC FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 68. ASIA-PACIFIC FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 69. ASIA-PACIFIC FACIAL AESTHETICS MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 70. CHINA FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 71. CHINA FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 72. CHINA FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 73. JAPAN FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 74. JAPAN FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 75. JAPAN FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 76. INDIA FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 77. INDIA FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 78. INDIA FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 79. AUSTRALIA FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 80. AUSTRALIA FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 81. AUSTRALIA FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 82. REST OF ASIA PACIFIC FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 83. REST OF ASIA PACIFIC FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 84. REST OF ASIA PACIFIC FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 85. LAMEA FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 86. LAMEA FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 87. LAMEA FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 88. LAMEA FACIAL AESTHETICS MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 89. BRAZIL FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 90. BRAZIL FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 91. BRAZIL FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 92. SAUDI ARABIA FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 93. SAUDI ARABIA FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 94. SAUDI ARABIA FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 95. COLOMBIA FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 96. COLOMBIA FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 97. COLOMBIA FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 98. REST OF LAMEA FACIAL AESTHETICS MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 99. REST OF LAMEA FACIAL AESTHETICS MARKET, BY APPLICATION, 2021-2031,($MILLION)
- TABLE 100. REST OF LAMEA FACIAL AESTHETICS MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 101.ABBVIE INC: COMPANY SNAPSHOT
- TABLE 102.ABBVIE INC: OPERATING SEGMENTS
- TABLE 103.ABBVIE INC: PRODUCT PORTFOLIO
- TABLE 104.ABBVIE INC: NET SALES,
- TABLE 105.ABBVIE INC: KEY STRATERGIES
- TABLE 106.MERZ PHARMA: COMPANY SNAPSHOT
- TABLE 107.MERZ PHARMA: OPERATING SEGMENTS
- TABLE 108.MERZ PHARMA: PRODUCT PORTFOLIO
- TABLE 109.MERZ PHARMA: NET SALES,
- TABLE 110.MERZ PHARMA: KEY STRATERGIES
- TABLE 111.GALDERMA LABORATORIES, L.P.: COMPANY SNAPSHOT
- TABLE 112.GALDERMA LABORATORIES, L.P.: OPERATING SEGMENTS
- TABLE 113.GALDERMA LABORATORIES, L.P.: PRODUCT PORTFOLIO
- TABLE 114.GALDERMA LABORATORIES, L.P.: NET SALES,
- TABLE 115.GALDERMA LABORATORIES, L.P.: KEY STRATERGIES
- TABLE 116.CANDELA SYNERON: COMPANY SNAPSHOT
- TABLE 117.CANDELA SYNERON: OPERATING SEGMENTS
- TABLE 118.CANDELA SYNERON: PRODUCT PORTFOLIO
- TABLE 119.CANDELA SYNERON: NET SALES,
- TABLE 120.CANDELA SYNERON: KEY STRATERGIES
- TABLE 121.VITAL ESTHETIQUE: COMPANY SNAPSHOT
- TABLE 122.VITAL ESTHETIQUE: OPERATING SEGMENTS
- TABLE 123.VITAL ESTHETIQUE: PRODUCT PORTFOLIO
- TABLE 124.VITAL ESTHETIQUE: NET SALES,
- TABLE 125.VITAL ESTHETIQUE: KEY STRATERGIES
- TABLE 126.TEOXANE: COMPANY SNAPSHOT
- TABLE 127.TEOXANE: OPERATING SEGMENTS
- TABLE 128.TEOXANE: PRODUCT PORTFOLIO
- TABLE 129.TEOXANE: NET SALES,
- TABLE 130.TEOXANE: KEY STRATERGIES
- TABLE 131.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
- TABLE 132.JOHNSON AND JOHNSON: OPERATING SEGMENTS
- TABLE 133.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
- TABLE 134.JOHNSON AND JOHNSON: NET SALES,
- TABLE 135.JOHNSON AND JOHNSON: KEY STRATERGIES
- TABLE 136.CYNOSURE: COMPANY SNAPSHOT
- TABLE 137.CYNOSURE: OPERATING SEGMENTS
- TABLE 138.CYNOSURE: PRODUCT PORTFOLIO
- TABLE 139.CYNOSURE: NET SALES,
- TABLE 140.CYNOSURE: KEY STRATERGIES
- TABLE 141.BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
- TABLE 142.BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS
- TABLE 143.BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
- TABLE 144.BAUSCH HEALTH COMPANIES INC.: NET SALES,
- TABLE 145.BAUSCH HEALTH COMPANIES INC.: KEY STRATERGIES
- TABLE 146.SINCLAIR PHARMACEUTICALS LIMITED: COMPANY SNAPSHOT
- TABLE 147.SINCLAIR PHARMACEUTICALS LIMITED: OPERATING SEGMENTS
- TABLE 148.SINCLAIR PHARMACEUTICALS LIMITED: PRODUCT PORTFOLIO
- TABLE 149.SINCLAIR PHARMACEUTICALS LIMITED: NET SALES,
- TABLE 150.SINCLAIR PHARMACEUTICALS LIMITED: KEY STRATERGIES
- TABLE 151.IPSEN: COMPANY SNAPSHOT
- TABLE 152.IPSEN: OPERATING SEGMENTS
- TABLE 153.IPSEN: PRODUCT PORTFOLIO
- TABLE 154.IPSEN: NET SALES,
- TABLE 155.IPSEN: KEY STRATERGIES
- TABLE 156.FOTONA D.O.O: COMPANY SNAPSHOT
- TABLE 157.FOTONA D.O.O: OPERATING SEGMENTS
- TABLE 158.FOTONA D.O.O: PRODUCT PORTFOLIO
- TABLE 159.FOTONA D.O.O: NET SALES,
- TABLE 160.FOTONA D.O.O: KEY STRATERGIES
- TABLE 161.ELAN AESTHETICS: COMPANY SNAPSHOT
- TABLE 162.ELAN AESTHETICS: OPERATING SEGMENTS
- TABLE 163.ELAN AESTHETICS: PRODUCT PORTFOLIO
- TABLE 164.ELAN AESTHETICS: NET SALES,
- TABLE 165.ELAN AESTHETICS: KEY STRATERGIES
- TABLE 166.ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT
- TABLE 167.ANIKA THERAPEUTICS, INC.: OPERATING SEGMENTS
- TABLE 168.ANIKA THERAPEUTICS, INC.: PRODUCT PORTFOLIO
- TABLE 169.ANIKA THERAPEUTICS, INC.: NET SALES,
- TABLE 170.ANIKA THERAPEUTICS, INC.: KEY STRATERGIES
- TABLE 171.CUTERA, INC.: COMPANY SNAPSHOT
- TABLE 172.CUTERA, INC.: OPERATING SEGMENTS
- TABLE 173.CUTERA, INC.: PRODUCT PORTFOLIO
- TABLE 174.CUTERA, INC.: NET SALES,
- TABLE 175.CUTERA, INC.: KEY STRATERGIES
- TABLE 176.EVOLUS INC.: COMPANY SNAPSHOT
- TABLE 177.EVOLUS INC.: OPERATING SEGMENTS
- TABLE 178.EVOLUS INC.: PRODUCT PORTFOLIO
- TABLE 179.EVOLUS INC.: NET SALES,
- TABLE 180.EVOLUS INC.: KEY STRATERGIES
- TABLE 181.REVANCE THERAPEUTICS: COMPANY SNAPSHOT
- TABLE 182.REVANCE THERAPEUTICS: OPERATING SEGMENTS
- TABLE 183.REVANCE THERAPEUTICS: PRODUCT PORTFOLIO
- TABLE 184.REVANCE THERAPEUTICS: NET SALES,
- TABLE 185.REVANCE THERAPEUTICS: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.FACIAL AESTHETICS MARKET SEGMENTATION
- FIGURE 2.FACIAL AESTHETICS MARKET,2021-2031
- FIGURE 3.FACIAL AESTHETICS MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.FACIAL AESTHETICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.FACIAL AESTHETICS MARKET,BY PRODUCT,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DERMAL FILLERS FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BOTULINUM TOXIN FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF MICRODERMABRASION FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CHEMICAL PEELS FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 18.FACIAL AESTHETICS MARKET,BY APPLICATION,2021(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF FACIAL LINE CORRECTION TREATMENT FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF SCAR TREATMENT FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF LIP ENHANCEMENT FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF RESTORATION OF VOLUME OR FULLNESS FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF OTHERS FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 24.FACIAL AESTHETICS MARKET,BY END USER,2021(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF SPECIALTY AND DERMATOLOGY CLINICS FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOSPITALS FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS FACIAL AESTHETICS MARKET,2021-2031(%)
- FIGURE 28.FACIAL AESTHETICS MARKET BY REGION,2021
- FIGURE 29.U.S. FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 30.CANADA FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 31.MEXICO FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 32.GERMANY FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 33.FRANCE FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 34.U.K. FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 35.ITALY FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 36.SPAIN FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 37.REST OF EUROPE FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 38.CHINA FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 39.JAPAN FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 40.INDIA FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 41.AUSTRALIA FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 42.REST OF ASIA PACIFIC FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 43.BRAZIL FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 44.SAUDI ARABIA FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 45.COLOMBIA FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 46.REST OF LAMEA FACIAL AESTHETICS MARKET,2021-2031($MILLION)
- FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 50.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 51.COMPETITIVE DASHBOARD
- FIGURE 52.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 53.ABBVIE INC.: NET SALES ,($MILLION)
- FIGURE 54.MERZ PHARMA.: NET SALES ,($MILLION)
- FIGURE 55.GALDERMA LABORATORIES, L.P..: NET SALES ,($MILLION)
- FIGURE 56.CANDELA SYNERON.: NET SALES ,($MILLION)
- FIGURE 57.VITAL ESTHETIQUE.: NET SALES ,($MILLION)
- FIGURE 58.TEOXANE.: NET SALES ,($MILLION)
- FIGURE 59.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)
- FIGURE 60.CYNOSURE.: NET SALES ,($MILLION)
- FIGURE 61.BAUSCH HEALTH COMPANIES INC..: NET SALES ,($MILLION)
- FIGURE 62.SINCLAIR PHARMACEUTICALS LIMITED.: NET SALES ,($MILLION)
- FIGURE 63.IPSEN.: NET SALES ,($MILLION)
- FIGURE 64.FOTONA D.O.O.: NET SALES ,($MILLION)
- FIGURE 65.ELAN AESTHETICS.: NET SALES ,($MILLION)
- FIGURE 66.ANIKA THERAPEUTICS, INC..: NET SALES ,($MILLION)
- FIGURE 67.CUTERA, INC..: NET SALES ,($MILLION)
- FIGURE 68.EVOLUS INC..: NET SALES ,($MILLION)
- FIGURE 69.REVANCE THERAPEUTICS.: NET SALES ,($MILLION)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook